vs
FONAR CORP（FONR）与READING INTERNATIONAL INC（RDI）财务数据对比。点击上方公司名可切换其他公司
READING INTERNATIONAL INC的季度营收约是FONAR CORP的2.0倍（$50.3M vs $25.5M），FONAR CORP净利率更高（8.0% vs -5.1%，领先13.1%），FONAR CORP同比增速更快（2.4% vs -14.2%），READING INTERNATIONAL INC自由现金流更多（$4.1M vs $-227.0K），过去两年READING INTERNATIONAL INC的营收复合增速更高（5.6% vs -0.3%）
FONAR是一家专业医疗技术企业，专注于设计、制造及销售包括立式、开放式在内的创新磁共振成像（MRI）设备，主要服务美国的医院、影像诊断中心及医疗机构，为临床诊断提供高精度扫描解决方案。
雷丁公司是总部位于美国费城的铁路企业，1924年起在宾夕法尼亚州东部及周边各州提供客运与货运运输服务，直至1976年被联合铁路公司收购。
FONR vs RDI — 直观对比
营收规模更大
RDI
是对方的2.0倍
$25.5M
营收增速更快
FONR
高出16.6%
-14.2%
净利率更高
FONR
高出13.1%
-5.1%
自由现金流更多
RDI
多$4.3M
$-227.0K
两年增速更快
RDI
近两年复合增速
-0.3%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $25.5M | $50.3M |
| 净利润 | $2.1M | $-2.6M |
| 毛利率 | — | — |
| 营业利润率 | 13.5% | -1.9% |
| 净利率 | 8.0% | -5.1% |
| 营收同比 | 2.4% | -14.2% |
| 净利润同比 | 4.7% | -14.5% |
| 每股收益（稀释后） | — | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FONRRDI
| Q4 25 | $25.5M | $50.3M | ||
| Q3 25 | $26.0M | $52.2M | ||
| Q2 25 | $27.3M | $60.4M | ||
| Q1 25 | $27.2M | $40.2M | ||
| Q4 24 | $24.9M | $58.6M | ||
| Q3 24 | $25.0M | $60.1M | ||
| Q2 24 | $25.9M | $46.8M | ||
| Q1 24 | $25.7M | $45.1M |
净利润FONRRDI
| Q4 25 | $2.1M | $-2.6M | ||
| Q3 25 | $2.3M | $-4.2M | ||
| Q2 25 | $729.3K | $-2.7M | ||
| Q1 25 | $2.5M | $-4.8M | ||
| Q4 24 | $2.0M | $-2.2M | ||
| Q3 24 | $3.1M | $-7.0M | ||
| Q2 24 | $830.4K | $-12.8M | ||
| Q1 24 | $1.9M | $-13.2M |
营业利润率FONRRDI
| Q4 25 | 13.5% | -1.9% | ||
| Q3 25 | 14.1% | -0.6% | ||
| Q2 25 | 5.3% | 4.8% | ||
| Q1 25 | 15.2% | -17.2% | ||
| Q4 24 | 11.9% | 2.6% | ||
| Q3 24 | 21.0% | -0.6% | ||
| Q2 24 | 7.4% | -16.4% | ||
| Q1 24 | 16.8% | -16.7% |
净利率FONRRDI
| Q4 25 | 8.0% | -5.1% | ||
| Q3 25 | 8.7% | -8.0% | ||
| Q2 25 | 2.7% | -4.4% | ||
| Q1 25 | 9.2% | -11.8% | ||
| Q4 24 | 7.9% | -3.8% | ||
| Q3 24 | 12.6% | -11.7% | ||
| Q2 24 | 3.2% | -27.4% | ||
| Q1 24 | 7.3% | -29.4% |
每股收益（稀释后）FONRRDI
| Q4 25 | — | $-0.11 | ||
| Q3 25 | — | $-0.18 | ||
| Q2 25 | — | $-0.12 | ||
| Q1 25 | — | $-0.21 | ||
| Q4 24 | — | $-0.11 | ||
| Q3 24 | — | $-0.31 | ||
| Q2 24 | — | $-0.57 | ||
| Q1 24 | — | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $121.0K | $10.5M |
| 总债务越低越好 | — | $185.1M |
| 股东权益账面价值 | $176.9M | $-18.2M |
| 总资产 | $217.2M | $434.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FONRRDI
| Q4 25 | $121.0K | $10.5M | ||
| Q3 25 | $122.0K | $8.1M | ||
| Q2 25 | $56.5M | $9.1M | ||
| Q1 25 | $123.0K | $5.9M | ||
| Q4 24 | $121.0K | $12.4M | ||
| Q3 24 | $136.0K | $10.1M | ||
| Q2 24 | $56.5M | $9.3M | ||
| Q1 24 | $134.0K | $7.5M |
总债务FONRRDI
| Q4 25 | — | $185.1M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $202.7M | ||
| Q3 24 | — | — | ||
| Q2 24 | $66.9K | — | ||
| Q1 24 | — | — |
股东权益FONRRDI
| Q4 25 | $176.9M | $-18.2M | ||
| Q3 25 | $174.9M | $-12.1M | ||
| Q2 25 | $172.6M | $-7.7M | ||
| Q1 25 | $171.9M | $-8.1M | ||
| Q4 24 | $169.8M | $-4.4M | ||
| Q3 24 | $168.7M | $1.6M | ||
| Q2 24 | $166.0M | $6.5M | ||
| Q1 24 | $165.8M | $18.0M |
总资产FONRRDI
| Q4 25 | $217.2M | $434.9M | ||
| Q3 25 | $218.4M | $435.2M | ||
| Q2 25 | $216.9M | $438.1M | ||
| Q1 25 | $214.9M | $441.0M | ||
| Q4 24 | $208.0M | $471.0M | ||
| Q3 24 | $212.3M | $495.7M | ||
| Q2 24 | $214.2M | $494.9M | ||
| Q1 24 | $209.6M | $494.9M |
负债/权益比FONRRDI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $171.0K | $4.3M |
| 自由现金流经营现金流 - 资本支出 | $-227.0K | $4.1M |
| 自由现金流率自由现金流/营收 | -0.9% | 8.2% |
| 资本支出强度资本支出/营收 | 1.6% | 0.3% |
| 现金转化率经营现金流/净利润 | 0.08× | — |
| 过去12个月自由现金流最近4个季度 | $5.7M | $-2.9M |
8季度趋势，按日历期对齐
经营现金流FONRRDI
| Q4 25 | $171.0K | $4.3M | ||
| Q3 25 | $1.7M | $295.0K | ||
| Q2 25 | $4.2M | $1.6M | ||
| Q1 25 | $3.1M | $-7.7M | ||
| Q4 24 | $2.2M | $8.0M | ||
| Q3 24 | $1.7M | $1.3M | ||
| Q2 24 | $4.6M | $-10.4M | ||
| Q1 24 | $2.8M | $-2.8M |
自由现金流FONRRDI
| Q4 25 | $-227.0K | $4.1M | ||
| Q3 25 | $-177.0K | $-246.0K | ||
| Q2 25 | $3.6M | $1.2M | ||
| Q1 25 | $2.6M | $-8.0M | ||
| Q4 24 | $1.5M | $7.0M | ||
| Q3 24 | $-148.0K | $-1.1M | ||
| Q2 24 | $4.2M | $-10.6M | ||
| Q1 24 | $2.6M | $-4.7M |
自由现金流率FONRRDI
| Q4 25 | -0.9% | 8.2% | ||
| Q3 25 | -0.7% | -0.5% | ||
| Q2 25 | 13.1% | 1.9% | ||
| Q1 25 | 9.4% | -19.8% | ||
| Q4 24 | 6.0% | 12.0% | ||
| Q3 24 | -0.6% | -1.8% | ||
| Q2 24 | 16.1% | -22.7% | ||
| Q1 24 | 10.2% | -10.4% |
资本支出强度FONRRDI
| Q4 25 | 1.6% | 0.3% | ||
| Q3 25 | 7.2% | 1.0% | ||
| Q2 25 | 2.4% | 0.6% | ||
| Q1 25 | 2.2% | 0.6% | ||
| Q4 24 | 3.0% | 1.7% | ||
| Q3 24 | 7.2% | 4.0% | ||
| Q2 24 | 1.6% | 0.5% | ||
| Q1 24 | 0.7% | 4.3% |
现金转化率FONRRDI
| Q4 25 | 0.08× | — | ||
| Q3 25 | 0.75× | — | ||
| Q2 25 | 5.79× | — | ||
| Q1 25 | 1.26× | — | ||
| Q4 24 | 1.14× | — | ||
| Q3 24 | 0.53× | — | ||
| Q2 24 | 5.54× | — | ||
| Q1 24 | 1.50× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FONR
| Managementof Diagnostic Imaging Centers | $23.2M | 91% |
| Manufacturingand Servicingof Medical Equipment | $2.4M | 9% |
RDI
| Cinema Exhibition Segment | $46.9M | 93% |
| Real Estate Revenue | $3.4M | 7% |
